Soligenix (SNGX) Competitors

DURECT (NASDAQ:DRRX) and Soligenix (NASDAQ:SNGX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, community ranking, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Which has higher valuation and earnings, DRRX or SNGX?

Soligenix has lower revenue, but higher earnings than DURECT. DURECT is trading at a lower price-to-earnings ratio than Soligenix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DURECT	$8.55M	2.85	-$27.62M	-$0.61	-1.29
Soligenix	$840K	7.26	-$6.14M	-$7.53	-0.32

Does the MarketBeat Community favor DRRX or SNGX?

DURECT received 38 more outperform votes than Soligenix when rated by MarketBeat users. However, 72.97% of users gave Soligenix an outperform vote while only 62.45% of users gave DURECT an outperform vote.

Company	Underperform	Outperform
DURECT	Outperform Votes 316 62.45%	Underperform Votes 190 37.55%
Soligenix	Outperform Votes 278 72.97%	Underperform Votes 103 27.03%

Does the media prefer DRRX or SNGX?

In the previous week, DURECT and DURECT both had 2 articles in the media. Soligenix's average media sentiment score of 0.24 beat DURECT's score of 0.00 indicating that Soligenix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DURECT	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Soligenix	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility & risk, DRRX or SNGX?

DURECT has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Soligenix has a beta of 1.83, meaning that its share price is 83% more volatile than the S&P 500.

Do insiders and institutionals hold more shares of DRRX or SNGX?

28.0% of DURECT shares are held by institutional investors. Comparatively, 3.6% of Soligenix shares are held by institutional investors. 3.2% of DURECT shares are held by insiders. Comparatively, 2.8% of Soligenix shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is DRRX or SNGX more profitable?

DURECT has a net margin of -198.58% compared to Soligenix's net margin of -1,473.38%. Soligenix's return on equity of -223.29% beat DURECT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DURECT	-198.58%	-300.62%	-65.17%
Soligenix	-1,473.38%	-223.29%	-74.18%

Do analysts recommend DRRX or SNGX?

DURECT presently has a consensus price target of $5.00, suggesting a potential upside of 537.43%. Given DURECT's stronger consensus rating and higher possible upside, research analysts clearly believe DURECT is more favorable than Soligenix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DURECT	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Soligenix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

DURECT beats Soligenix on 10 of the 17 factors compared between the two stocks.